+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

R

Actively Recruiting

The registry focuses on patients with venous thromboembolism VTE, including those often excluded from typical clinical trials such as pregnant women, elderly patients, and those with serious health conditions. It aims to improve medical knowledge and patient care by collecting detailed data on these patients clinical status and treatment outcomes. The project also seeks to develop predictive scores to identify patients at higher risk of complications from thromboembolic disease. This observational registry collects extensive information on patients diagnosed with VTE, including details on coexisting conditions, antithrombotic treatment type, dose, and duration, as well as outcomes during the first three months of therapy. It captures data on VTE recurrences, bleeding complications, and deaths, providing insights into real-world treatment and patient management. Participants provide informed consent and are followed for at least three months to monitor clinical outcomes. The registry supports physicians by giving access to data on patients with similar profiles to help manage complex cases. The main outcomes measured include VTE events and complications over a three-year period, supporting ongoing improvements in patient care and risk assessment.

All Genders
257 locations
S

Actively Recruiting

This research aims to find out if a nursing educational program can reduce anxiety in patients scheduled for treatment in a hyperbaric chamber. The study compares this new program with the usual care provided to patients before their treatment begins. The goal is to see if providing detailed information and support before the first session helps lower anxiety levels. Participants in the experimental group will receive an educational intervention with audiovisual materials explaining how the hyperbaric chamber works and what to expect during treatment. This intervention starts on the day the treatment is prescribed, including an informative brochure and a half-hour session before the first treatment. The control group will receive the usual brief explanation currently offered before entering the chamber. During the study, participants will be assessed for anxiety using the STAI questionnaire during the first week of treatment. Researchers will monitor and compare anxiety levels between groups to evaluate the effectiveness of the nursing intervention. The study involves randomized assignment to groups and single blinding. Overall participation will cover the treatment period beginning with the first session in the chamber.

Age: 18Years - 100YearsAll GendersPhase Not Applicable
1 location